- Generic Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Generic Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials | Start Date 06-07-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Dispersion for injection
- Ontology Form/Route
- dispersioninjection.intramuscular
- Name Basis
- Other
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 14040000
Code | Start Date | End Date |
---|---|---|
42029111000001101 | 06-07-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Andusomeran | Based on Ingredient Substance | 100 microgram | 1 ml |
Name
Andusomeran
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
1
Parent Products
-
VTMCOVID-19 vaccine
-
VMP(Current) Generic Spikevax XBB.1.5 COVID-19 mR...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
2.5 ml | ||
25 ml |